Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001062993-21-008252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-03 | 2021-09-02 | BIO | Crowley Michael | EVP, GBL Commercial Ops | M - OptEx | $0.00 | +433 | 4,102 | +12% | $0 |
| D | 2021-09-03 | 2021-09-02 | BIO | Crowley Michael | EVP, GBL Commercial Ops | F - Tax | $825.77 | -215 | 3,887 | -5% | -$177.5K |
| DM | 2021-09-03 | 2021-09-01 | BIO | Crowley Michael | EVP, GBL Commercial Ops | A - Grant | $0.00 | +3,242 | 1,621 | New | $0 |
| D | 2021-09-03 | 2021-09-02 | BIO | Crowley Michael | EVP, GBL Commercial Ops | M - OptEx | $0.00 | -433 | 1,300 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2021-09-02 | M | A | 433 | $0.00 | 4,102 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2021-09-02 | F | D | 215 | $825.77 | 3,887 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-09-01 | A | A | 1,621 | $0.00 | 1,621 | D | $0.00 · — to — | 1,621 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| 4 | Derivative | Restricted Stock Units | 2021-09-02 | M | D | 433 | $0.00 | 1,300 | D | $0.00 · — to — | 433 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-01 | A | A | 1,621 | $0.00 | 1,621 | D | $814.95 · — to 2031-09-01 | 1,621 Bio-Rad A Common Stock | (F4) The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. |